I-Mab (IMAB) has a market capitalization of $542.01M and trades at $2.88. The 52-week range is 0.595-6.79.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-4.46.
The stock has a beta of 1.46, operates in the Healthcare sector.
